• The company boasts state-of-the-art technology with multi-usable helmets for different indications and more indications likely to be approved.
• International sales are another growth opportunity where the company has hardly scratched the surface.
• The shares are modestly valued, given 30%+ revenue growth and 75%+ gross margins, even if there is little in the way of operational leverage and profits are not near.
• The company isn’t without competition though, and these are not sitting still either.
• Looking for more investing ideas like this one? Get them exclusively at SHU Growth Portfolio. Learn More »

BrainsWay Stock Looks Attractive